June 29, 2018
Novartis aims at spinoff of Alcon eye care devices business
Novartis on Friday said it intends to spinoff Alcon, its eye care division, into a separately-traded standalone company, which would…
Pharmaceuticals, Biotechnology and Life Sciences
Tag: Novartis
June 26, 2018
Long way for psoriasis patients despite clear or almost clear skin being more achievable
The impact of psoriasis is more than skin deep and can have a profound effect on people’s physical and emotional…
June 18, 2018
Alcon AcrySof IQ PanOptix trifocal intraocular lens shows superior visual performance in head-to-head trial post-cataract surgery
Novartis’s eye care division Alcon unveils new data showing significantly improved near and intermediate distance vision with the AcrySof IQ…
June 4, 2018
Novartis to seek approval of Kisqali plus fulvestrant for postmenopausal women with advanced breast cancer
Novartis on Sunday announced positive results from the third Phase III trial of Kisqali in advanced or metastatic breast cancer.
June 1, 2018
Novartis’s first targeted migraine prevention therapy to patients in Europe
Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended approval for Novartis’s Aimovig…
June 1, 2018
Sandoz receives positive CHMP opinion for proposed biosimilar adalimumab
Sandoz said Friday that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has…
May 30, 2018
FDA expedites review of Novartis drug Promacta for first-line severe aplastic anemia
Novartis said Tuesday that the US Food and Drug Administration (FDA) has accepted the its supplemental New Drug Application (sNDA)…
May 29, 2018
Novartis reports significant improvement in symptom frequency and quality of life domains with Entresto
Novartis has gotten new evidence from the CHAMP-HF registry comparing Entresto patients to patients not taking Entresto, which showed that…
May 24, 2018
Novartis’s Zessly approved in Europe
Novartis’s Sandoz has secured European Commission’s approval for biosimilar Zessly, the company said Thursday.
May 18, 2018
FDA approves Aimovig for migraine
The US Food and Drug Administration (FDA) has approved Novartis’s and Amgen’s Aimovig (erenumab) for the preventive treatment of migraine in…